Results 131 to 140 of about 16,591 (206)

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti‐Cancer Immunity Across the Lifespan

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos, Esther M. Peluso, Sophia L. Cha, Melissa G. Lechner, Maureen A. Su   +4 more
wiley   +1 more source

Prognostic Factors of Castration-Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot-Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94). [PDF]

Int J Urol
Sasaki T, Igarashi A, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, Yamasaki T, Inoue T.   +18 more
europepmc   +1 more source

Single Potential Analysis of Cavernous Electric Activity in Impotent Patients: a Possible Diagnostic Method for Autonomic Cavernous Dysfunction and Cavernous Smooth Muscle Degeneration. [PDF]

, 1991
Allhoff, E. P., Anton, P., Djamilian, Mohamad H., Jonas, Udo, Riese, W. de, Stief, Christian Georg   +5 more
core   +1 more source

The role of STEAP1 in the sensitivity of C4-2B prostate cancer cells to taxane-based chemotherapy [PDF]

Prostate cancer (PCa) is the third-leading cause of cancer death in men worldwide. As a precursor to PCa, prostatic intraepithelial neoplasia (PIN) lesions are defined as a preneoplastic growth of the prostate that could develop into carcinoma and ...
Coelho, Rafaella Severino
core  

Sex Differences in Cancer Immunotherapy—Clinical Evidence and Mechanisms With a Focus on NSCLC

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Accumulating evidence suggests that the immune system shows subtle but relevant differences between men and women. These differences may have an impact on cancer development and TME composition as well as responses to and adverse events elicited by immunotherapies.
Eva Krieghoff‐Henning, Balagopal Pai, Maike Collienne, Isabel Ben‐Batalla, Sonja Loges   +4 more
wiley   +1 more source

Two Cases of Metastatic Castration-Resistant Prostate Cancer With Long-Term Survival Treated With Abiraterone. [PDF]

Clin Case Rep
Une M, Yamamoto S, Fuse H, Fujiwara R, Yonese J, Noda K.   +5 more
europepmc   +1 more source

ODC1 Polyamine Metabolism Drives Prostate Cancer via AKT and Splicing

Journal of Cellular and Molecular Medicine, Volume 30, Issue 5, March 2026.
ABSTRACT Prostate cancer is an aggressive disease with limited quantifiable biomarkers. One gene of interest is ODC1, which encodes ornithine decarboxylase, the rate‐limiting enzyme converting ornithine to putrescine in polyamine metabolism. Although ODC1 is known to be involved in prostate cancer development, exactly how it drives the disease ...
Jian Ma, Ting Pan, Shengli Sun, Musitapa Mutalifu, Wei Yang, Yue Niu, Peng Chen   +6 more
wiley   +1 more source

Evaluating synergistic versus additive effects of the triplet regimen in metastatic castration-sensitive prostate cancer: a modeling analysis. [PDF]

Jpn J Clin Oncol
Hata S, Suzuki S, Fujinami H, Yamanaka N, Shin T.   +4 more
europepmc   +1 more source

Treatment-related changes in the prostate: past, present and future therapies. [PDF]

Histopathology
Collins K, Cheng L.
europepmc   +1 more source

Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study. [PDF]

Sci Rep
Wänman J, Farhang M, Nyström H, Styrke J, Häggström C, Stattin P, Crnalic S.   +6 more
europepmc   +1 more source